Fluorescence polarization-based assays for detecting compounds binding to inactive c-Jun N-terminal kinase 3 and p38α mitogen-activated protein kinase.

Abstract Two fluorescein-labeled pyridinylimidazoles were synthesized and evaluated as probes for the binding affinity determination of potential kinase inhibitors to the c-Jun N-terminal kinase3 (JNK3) and p38α mitogen-activated protein kinase (MAPK). Fluorescence polarization ( FP)-based competition binding assays were developed for both enzymes using 1-(3′,6′-dihydroxy-3-oxo-3 H -spiro[ isobenzofuran-1,9′- xanthen]-5-yl)-3-(4-((4-(4-(4-fluorophenyl)-2-(methylthio)-1 H -imidazol-5-yl)pyridin-2-yl)amino)phenyl)thiourea ( 5 ) as an FPprobe (JNK3: K d = 3.0 nM; p38α MAPK: K d = 5.7 nM). The validation of the assays with known inhibitors of JNK3 and p38α MAPK revealed that both FPassays correlate very well with inhibition data received by the activity assays. This, in addition to the viability of both FP-based binding assays for the high-throughput screeningprocedure, makes the assays suitable as inexpensive prescreening protocols for JNK3 and p38α MAPK inhibitors.